Home » Topics » BioWorld Science

BioWorld Science
RSS

AdCh3NSmut1/MVA-NSmut did not protect against HCV infection in phase I/II trial

May 30, 2019

Amicus and University of Pennsylvania expand gene therapy collaboration

May 30, 2019

NRF2 gene polymorphism tied to emphysema development in smokers

May 30, 2019

Michael J. Fox Foundation awards Casma Therapeutics grant to advance PD drug development

May 30, 2019

Merck & Co. discovers IDO1 inhibitors

May 30, 2019

Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint

May 30, 2019

Jubilant Biosys describes PD-1/PD-L1 interaction inhibitors

May 30, 2019

Metacrine reports phase Ib interim data on FXR agonist MET-409 in NASH

May 30, 2019

German researchers present new adenosine A2A receptor ligands

May 30, 2019

Xeomin approved in E.U. for treatment of chronic sialorrhea in adults

May 30, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...